810 F.3d 827
D.C. Cir.2016Background
- Congress directed FDA to create a 12‑member Tobacco Products Scientific Advisory Committee (TPSAC) to report on menthol cigarettes under the Family Smoking Prevention and Tobacco Control Act.
- Plaintiffs (menthol tobacco producers/affiliates) challenged FDA appointments of three TPSAC members, alleging statutory/conflict‑of‑interest violations because members testified in tobacco litigation and had ties to smoking‑cessation drug makers.
- Plaintiffs alleged three injuries: (1) increased risk of adverse FDA regulation of menthol products; (2) risk that committee members would access and misuse plaintiffs’ confidential information; and (3) that members would shape the menthol report to bolster their expert‑witness/consulting businesses and harm plaintiffs’ reputations.
- The district court granted summary judgment for plaintiffs, dissolved the committee, enjoined use of the menthol report, and ordered reconstitution of the committee.
- On appeal, the D.C. Circuit reviewed the summary judgment de novo and focused first on jurisdictional standing and ripeness of plaintiffs’ asserted injuries.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Standing to challenge appointments based on procedural conflict‑of‑interest violations (risk of adverse FDA rule) | FDA’s failure to follow conflict procedures increased likelihood of a harmful menthol rule; procedural rights violation alone supports standing | Risk of a final FDA rule is speculative; any causation is too attenuated and not imminently threatening | No standing — increased risk from appointments too remote and speculative to be imminent |
| Ripeness/imminence of challenge to advisory committee composition | Plaintiffs need not await final rule because procedural‑rights claims relax causation requirement | Ripeness doctrine bars adjudication where contingent future events (rule issuance, reliance on report) may not occur | Not ripe — contingencies (whether FDA issues a rule and how it uses the report) make injury speculative |
| Risk of misuse of confidential information by committee members | Members accessed confidential materials and could disclose or use them in litigation, causing injury | No evidence of past or impending misuse; illegal disclosure would incur criminal/civil penalties and depends on independent actor choices | No standing — plaintiffs failed to show imminent risk of misuse; speculative and dependent on unlawful acts by third parties |
| Alleged shaping of report to benefit members’ expert witness businesses/reputational harm | Members would tailor report to support their testimony, causing present and future litigation/reputational injury | Plaintiffs lack evidence linking report‑shaping to concrete injury; little proof report altered testimony or that menthol cases would rely on it | No standing — insufficient evidence that report was shaped to cause imminent, concrete injury or reputational harm |
Key Cases Cited
- Lujan v. Defenders of Wildlife, 504 U.S. 555 (standing requires injury‑in‑fact, causation, redressability)
- Florida Audubon Soc’y v. Bentsen, 94 F.3d 658 (relaxed standing for procedural violations still requires distinct risk to particularized interest)
- Texas v. United States, 523 U.S. 296 (ripeness: claims resting on contingent future events are not ripe)
- Atlantic States Legal Found. v. EPA, 325 F.3d 281 (challenge not ripe where action depends on further state rulemaking)
- Metcalf v. Nat’l Petroleum Council, 553 F.2d 176 (no standing to challenge advisory committee where agency had not acted on recommendations)
- Wyoming Outdoor Council v. U.S. Forest Serv., 165 F.3d 43 (procedural‑rights standing can be found where record shows concrete danger and predicate actions have progressed)
- Meese v. Keene, 481 U.S. 465 (reputational injury recognized where supported by concrete evidence)